OLMA insider plans 12,500-share stock sale

Cyrus L. Harmon filed to sell 12,500 common shares of OLMA through Fidelity Brokerage Services LLC on July 24, 2026 on NASDAQ, with an indicated value of $146,419.49.

Rhea-AI Filing Summary

Cyrus L. Harmon filed to sell 12,500 common shares of OLMA through Fidelity Brokerage Services LLC on July 24, 2026 on NASDAQ, with an indicated value of $146,419.49. The filing also reports that Harmon sold 12,500 common shares on July 23, 2026 for $144,737.53, originally acquired as founders shares on March 20, 2007 as compensation.

Key Figures

Planned shares to be sold: 12,500 shares Planned sale value: $146,419.49 Recent shares sold: 12,500 shares +2 more

5 metrics

Planned shares to be sold 12,500 shares Common stock sale planned for July 24, 2026 on NASDAQ

Planned sale value $146,419.49 Indicated aggregate value for 12,500 common shares

Recent shares sold 12,500 shares Common stock sold on July 23, 2026 during past 3 months

Recent sale proceeds $144,737.53 Aggregate amount for 12,500 common shares sold on July 23, 2026

Acquisition date of founders shares 03/20/2007 Original acquisition date of founders shares received as compensation

Key Terms

Founders Shares, Compensation, Securities Sold During The Past 3 Months

3 terms

Founders Shares financial

"Common | 03/20/2007 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

Compensation financial

"12500 | 03/20/2007 | Compensation"

Securities Sold During The Past 3 Months regulatory

"144: Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the OLMA Form 144 filing by Cyrus L. Harmon disclose?

The filing shows Cyrus L. Harmon plans to sell 12,500 OLMA common shares on July 24, 2026 via Fidelity Brokerage Services LLC, with an estimated value of $146,419.49 on NASDAQ.

How many OLMA shares has Cyrus L. Harmon recently sold or proposed to sell?

Cyrus L. Harmon reported a proposed sale of 12,500 OLMA common shares and a prior sale of another 12,500 shares, totaling 25,000 shares reported across the planned and recent transactions.

What prices are associated with Cyrus L. Harmon’s OLMA share transactions?

The proposed sale of 12,500 OLMA shares is valued at $146,419.49, while the sale during the past three months for the same number of shares totaled $144,737.53, according to the Form 144 disclosure.

When did Cyrus L. Harmon acquire the OLMA shares reported in the Form 144?

The Form 144 notes the OLMA common shares were acquired on March 20, 2007 as founders shares received as compensation from the issuer, and are now being reported for potential resale.

Which broker is handling Cyrus L. Harmon’s proposed OLMA share sale?

The planned sale of 12,500 OLMA common shares is to be executed through Fidelity Brokerage Services LLC, located at 900 Salem Street, Smithfield, RI 02917, with trading indicated on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/24/2026 - 03:11 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001831410
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Olema Pharmaceuticals, Inc.
SEC File Number	001-39712
Address of Issuer	780 BRANNAN STREET SAN FRANCISCO CALIFORNIA 94103
Phone	(415) 651-3316
Name of Person for Whose Account the Securities are To Be Sold	Harmon Cyrus
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	12500	146419.49	87347471	07/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/20/2007	Founders Shares	Issuer			12500	03/20/2007	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Cyrus L. Harmon 780 Brannan Street San Francisco CA 94103	Common	07/23/2026	12500	144737.53

144: Remarks and Signature

Remarks
Date of Notice	07/24/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Cyrus L. Harmon
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)